Symbols

Symbols

ATYR

ATYR

aTyr Pharma under investigation for securities fraud.

Friday Nov 07, 2025

aTyr Pharma: RBC Downgrades to Sector Perform, PT Cut to $1 from $1.5

aTyr Pharma Class Action Lawsuit: Shareholders Encouraged to Contact Schall Law Firm

Jasper Therapeutics Faces Class Action Lawsuit Over Misleading Statements.

WPP plc faces class action lawsuit over misleading revenue forecasts.

aTyr Pharma investors sue for Securities Exchange Act violations.

aTyr Pharma Faces Investigation for Securities Law Violations.

Quanex investors sue over equipment maintenance and tooling issues.

Thursday Nov 06, 2025

aTyr Pharma Q3 revenue $92.9mln, expects SSc-ILD study completion in H1 2026.

aTyr Pharma investors may have been misled about Efzofitimod's efficacy.

aTyr Pharma investors sue over alleged misleading statements and drug efficacy claims.

Wednesday Nov 05, 2025

aTyr Pharma Class Action Lawsuit Filed, Alleging Securities Fraud.

Tuesday Nov 04, 2025

aTyr Pharma sued for Securities Exchange Act violations.

aTyr Pharma investors file class action securities lawsuit over alleged fraud.

Monday Nov 03, 2025

ATyr Pharma under investigation for securities fraud, deadline to seek lead plaintiff is December 8, 2025.

Investigation into ATyr Pharma's Securities Practices and Potential Class Action Lawsuit

aTyr Pharma Under Investigation for Securities Fraud

aTyr Pharma investors may be eligible for lead plaintiff appointment.

aTyr Pharma Faces Class Action Lawsuit Over Misleading Statements.

Quantum Corp. faces class action over allegedly false financial statements.